Previously, BRAF mutations were associated with older age, tall-cell variants, extrathyroidal extensions, positive surgical margins, lymph-node metastasis, and stage IV disease [9, 10]. This evidence concerns the gene BRAF and metastatic malignant neoplasm in the lymph nodes.